Virginia Tech® home

In Person Lecture: Bone and Blood Interactions in the Bone Marrow Microenvironment

Insert your title here

Joy Wu, M.D., Ph.D.

Associate Professor
Chief, Division of Endocrinology, Gerontology, and Metabolism
Stanford University School of Medicine

Timothy A. Johnson Medical Scholar Lecture: Bone and Blood Interactions in the Bone Marrow Microenvironment

Archived video

Loading player for https://video.vt.edu/media/1_v0y94wxy...

About this Seminar

Osteoblasts and their progenitors play an important role in the support of hematopoiesis within the bone marrow microenvironment. From mesenchymal stem cells to fully mature osteoblasts, cells at each stage of differentiation play unique roles in supporting hematopoietic development. Dr. Wu and her lab have reported that in mice parathyroid hormone receptor (PTH1R) signaling in osteoprogenitors is required for normal B cell precursor differentiation, and for trafficking of maturing B cells out of the bone marrow. The lab has also found that numbers of maturing myeloid, T cell, and erythroid populations were increased in the bone marrow of mice lacking PTH1R in osteoprogenitors (PTH1R-OsxKO mice). This increase in maturing hematopoietic populations was not associated with an increase in progenitor numbers or proliferation. The spleens of PTH1R-OsxKO mice were small with decreased numbers of all hematopoietic populations, suggesting that trafficking of mature hematopoietic populations between bone marrow and spleen is impaired in the absence of PTH1R in osteoprogenitors. RNA sequencing of osteoprogenitors and their descendants in bone and bone marrow revealed several candidate niche factors that may play a role in supporting hematopoiesis in the bone marrow microenvironment. Research studies have also examined the clinical relevance of bone health to hematopoiesis in humans, and Dur. Wu and her team have demonstrated that PTH can influence the hematopoietic niche in postmenopausal women with osteoporosis. The lessons learned from the hematopoietic niche are applicable to cancer metastases to bone, and the lab has also shown that PTH can decrease breast cancer bone metastases in mice. Therefore PTH1R signaling in the osteoblast lineage plays a critical role in the reciprocal interactions between bone and the bone marrow microenvironment, with relevance to hematopoiesis and cancer.

Additional Details

This is a free event hosted by the Fralin Biomedical Research Institute and the Virginia Tech Carilion School of Medicine. The Timothy A. Johnson Medical Scholar Lecture Series hosts clinician scientists who are exploring frontiers of medicine. These lectures are principally intended for Virginia Tech Carilion School of Medicine students and Virginia Tech students in the Translational Biology, Medicine, and Health graduate program. Virginia Tech and Carilion Clinic faculty, staff, and students may also attend.

You May Also Be Interested In...

  • Home Item
    The Role of Exercise in Memory Function
    The Role of Exercise in Memory Function , home

    May 23, 2025, 11:00 a.m. | Henriette van Praag, Ph.D., Associate Professor, Department of Biomedical Science, Charles E. Schmidt College of Medicine, Florida Atlantic University | Co-Sponsored by the Center for Exercise Medicine Research, Fralin Biomedical Research Institute

  • Home Item
    Pathways and Regulation of Cardiac Nav1.5 Channel Trafficking in Adult Myocytes
    Pathways and Regulation of Cardiac Nav1.5 Channel Trafficking in Adult Myocytes , home

    May 30, 2025, 11:00 a.m. | Gea-Ny Tseng, Ph.D., Professor, Department of Physiology and Biophysics, Virginia Commonwealth University School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Center for Vascular and Heart Research

  • Home Item
    Targeting Acquired Dependencies During Tumor Evolution
    Targeting Acquired Dependencies During Tumor Evolution , home

    June 6, 2025, 11:00 a.m. | Kris Wood, Ph.D., Associate Professor, Department of Pharmacology and Cancer Biology, Duke University School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Cancer Research Center – D.C.